(Q43732741)

26 November 2017

Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group project (English)

1 reference

26 November 2017

1 reference

1 reference

5

1 reference

26 November 2017

7

1 reference

26 November 2017

Rebecca J Deyell

2

0 references

author name string

Yaël P Mossé

1

1 reference

26 November 2017

Frank Berthold

3

1 reference

26 November 2017

Akira Nagakawara

4

1 reference

26 November 2017

Tom Monclair

6

1 reference

26 November 2017

Andrew D Pearson

8

1 reference

26 November 2017

Wendy B London

9

1 reference

26 November 2017

Katherine K Matthay

10

1 reference

26 November 2017

13 September 2013

1 reference

26 November 2017

Pediatric Blood Cancer

1 reference

26 November 2017

61

1 reference

26 November 2017

4

1 reference

26 November 2017

627-635

1 reference

Outcomes for children and adolescents with cancer: challenges for the twenty-first century

26 November 2017

1 reference

Neuroblastoma in adults: Incidence and survival analysis based on SEER data

21 January 2018

1 reference

The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report

21 January 2018

1 reference

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

21 January 2018

1 reference

Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study.

21 January 2018

1 reference

Neuroblastoma in adolescents

21 January 2018

1 reference

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

21 January 2018

1 reference

Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas

21 January 2018

1 reference

Trends in cancer incidence among children in the U.S.

21 January 2018

1 reference

Neuroblastoma in adolescents

21 January 2018

1 reference

Neuroblastoma in adults and adolescents: an indolent course with poor survival

21 January 2018

1 reference

Neuroblastoma in adolescents and adults: the Memorial Sloan-Kettering experience

21 January 2018

1 reference

Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma

21 January 2018

1 reference

Association of age at diagnosis and genetic mutations in patients with neuroblastoma.

21 January 2018

1 reference

Multiagent chemotherapy for children with metastatic neuroblastoma: a report from Childrens Cancer Study Group

21 January 2018

1 reference

Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group project

21 January 2018

1 reference

Chromosome 1p and 11q deletions and outcome in neuroblastoma

21 January 2018

1 reference

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

21 January 2018

1 reference

Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma

21 January 2018

1 reference

Response, survival, and toxicity after iodine-131-metaiodobenzylguanidine therapy for neuroblastoma in preadolescents, adolescents, and adults

21 January 2018

1 reference

Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group

21 January 2018

1 reference

Neuroblastoma in adolescents: genetic and clinical characterisation

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PBC.24777

1 reference

26 November 2017

1 reference